药品注册申请号:209029
申请类型:ANDA (仿制药申请)
申请人:PRINSTON INC
申请人全名:PRINSTON PHARMACEUTICAL INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 SILODOSIN SILODOSIN CAPSULE;ORAL 4MG No No AB 2022/01/04 2022/01/04 Prescription
002 SILODOSIN SILODOSIN CAPSULE;ORAL 8MG No No AB 2022/01/04 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/01/04 ORIG-1(原始申请) Approval STANDARD
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:SILODOSIN; 剂型/给药途径:CAPSULE;ORAL; 规格:4MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022206 001 NDA RAPAFLO SILODOSIN CAPSULE;ORAL 4MG Discontinued Yes No AB 2008/10/08 ABBVIE
204726 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2017/03/31 CHARTWELL RX
206541 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No Yes AB 2018/12/03 LUPIN LTD
209745 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2018/12/03 AMNEAL PHARMS CO
210687 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2018/12/03 MSN
211060 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2018/12/03 AJANTA PHARMA LTD
211166 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2018/12/03 MACLEODS PHARMS LTD
210626 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2018/12/10 AUROBINDO PHARMA LTD
204793 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2020/02/14 HETERO LABS LTD V
213230 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2022/01/03 CREEKWOOD PHARMS
209029 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Prescription No No AB 2022/01/04 PRINSTON INC
204816 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Discontinued No No AB 2022/12/08 ZYDUS PHARMS
210396 001 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 4MG Discontinued No No AB 2025/02/10 TORRENT
>>>活性成分:SILODOSIN; 剂型/给药途径:CAPSULE;ORAL; 规格:8MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022206 002 NDA RAPAFLO SILODOSIN CAPSULE;ORAL 8MG Discontinued Yes No AB 2008/10/08 ABBVIE
204726 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2017/03/31 CHARTWELL RX
206541 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/03 LUPIN LTD
209745 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/03 AMNEAL PHARMS CO
210687 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/03 MSN
211060 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/03 AJANTA PHARMA LTD
211166 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/03 MACLEODS PHARMS LTD
210626 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2018/12/10 AUROBINDO PHARMA LTD
204793 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2020/02/14 HETERO LABS LTD V
213230 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2022/01/03 CREEKWOOD PHARMS
209029 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Prescription No No AB 2022/01/04 PRINSTON INC
204816 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Discontinued No No AB 2022/12/08 ZYDUS PHARMS
210396 002 ANDA SILODOSIN SILODOSIN CAPSULE;ORAL 8MG Discontinued No No AB 2025/02/10 TORRENT
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database